Cargando…
ASSOCIATION BETWEEN CARDIOVASCULAR COMORBIDITIES AND MORTALITY AMONGST SARSCOV-2 PATIENTS
Autores principales: | Douen, Aaron, Oh, Jeremy Jaehwan, Sukhoo-Pertab, Marc, Tan, Samuel, Bowser, Carly, Lindsey, Madison, Ramdass, Prakash, Hai, Ofek, Juang, George, Toreli, Aleksandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972499/ http://dx.doi.org/10.1016/S0735-1097(22)02476-7 |
Ejemplares similares
-
SHOULD BETA BLOCKERS STILL BE CONSIDERED SECOND LINE IN PATIENTS WITH SARS-COV-2
por: Tan, Samuel, et al.
Publicado: (2023) -
THE CHANGING LANDSCAPE OF CARDIAC COMORBIDITIES AND IN-HOSPITAL CARDIAC COMPLICATIONS MEDIATING COVID-19 MORTALITY BETWEEN 2020 AND 2021
por: Basala, Thomas, et al.
Publicado: (2023) -
BODY MASS INDEX, INFLAMMATION AND SEVERITY IN HOSPITALIZED COVID-19 PATIENTS: RESULTS FROM A CHICAGO AND MADRID RETROSPECTIVE COHORT STUDY
por: Park, Aaron, et al.
Publicado: (2023) -
THE ASSOCIATION OF ANTICOAGULATION BEFORE ADMISSION AND SURVIVAL OF PATIENTS WITH COVID-19
por: Kuno, Toshiki, et al.
Publicado: (2021) -
SOCIAL DETERMINANTS OF HEALTH DISPARITIES FOR COVID-19 MITIGATION MEASURES AMONG ADULTS WITH CARDIOVASCULAR DISEASE IN UNITED STATES
por: Hagan, Kobina, et al.
Publicado: (2021)